EUVIMEDEUVIMED entdecken
Open Access

Mitochondrial haplogroups and cognitive progression in Parkinson’s disease

Ganqiang Liu iD, Chunming Ni, Jiamin Zhan, Weimin Li, Junfeng Luo, Zhixiang Liao, Joseph J Locascio, Wenbiao Xian, Ling Chen, Zhong Pei iD, Jean-Christophe Corvol, Jodi Maple-Grødem und 23 weitere

Brain · 05.01.2023 · 146 (1) · 42-49

DOI: 10.1093/brain/awac327 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain, online erschienen am 08.11.2022. Verfasst von Ganqiang Liu und 34 weiteren Autor:innen. Beteiligte Einrichtung: Neurobiology Research Center, School of Medicine, Shenzhen Campus of Sun Yat-sen University, Shenzhen, Guangdong 518107, China. Hauptthemen laut MEDLINE: Parkinson Disease. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Medical Research Council, NINDS NIH HHS, Fundamental Research Funds.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mitochondria are a culprit in the onset of Parkinson’s disease, but their role during disease progression is unclear. Here we used Cox proportional hazards models to exam the effect of variation in the mitochondrial genome on longitudinal cognitive and motor progression over time in 4064 patients with Parkinson’s disease. Mitochondrial macro-haplogroup was associated with reduced risk of cognitive disease progression in the discovery and replication population. In the combined analysis, patients with the super macro-haplogroup J, T, U# had a 41% lower risk of cognitive progression with P = 2.42 × 10−6 compared to those with macro-haplogroup H. Exploratory analysis indicated that the common mitochondrial DNA variant, m.2706A>G, was associated with slower cognitive decline with a hazard ratio of 0.68 (95% confidence interval 0.56–0.81) and P = 2.46 × 10−5. Mitochondrial haplogroups were not appreciably linked to motor progression. This initial genetic survival study of the mitochondrial genome suggests that mitochondrial haplogroups may be associated with the pace of cognitive progression in Parkinson’s disease over time.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseHumansHaplotypesMitochondriaDNA, MitochondrialDisease ProgressionCognition

Stichwörter der Autor:innen

Parkinson’s diseasecognitive progressionmitochondrial haplogroups

Substanzen

DNA, Mitochondrial

Autor:innen und Institutionen

  • Neurobiology Research Center, School of Medicine, Shenzhen Campus of Sun Yat-sen University, Shenzhen, Guangdong 518107, China.
  • APDA Center for Advanced Parkinson Research, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.
  • Neurogenomics Lab, Harvard Medical School, Brigham and Women's Hospital, Boston, MA 02115, USA.
  • Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.
  • Department of Neurology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510080, China.
  • Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, Institut National de la Santé et de la Recherche Médicale, Centre National de la Recherche Scientifique, Assistance Publique Hôpitaux de Paris, Dép…

ORCID-Profile: Ganqiang Liu, Zhong Pei, Alexis Elbaz

Förderung

  • Medical Research Council
  • NINDS NIH HHS
  • Fundamental Research Funds
  • Central Universities
  • Sun Yat-sen University
  • National Natural Science Foundation of China
  • Guangdong Basic and Applied Basic Research Foundation
  • Shenzhen Fundamental Research Program

Zitieren

APA

Liu, G., Ni, C., Zhan, J., Li, W., Luo, J., Liao, Z., Locascio, J. J., Xian, W., Chen, L., Pei, Z., Corvol, J. C., Maple-Grødem, J., Campbell, M. C., Elbaz, A., Lesage, S., Brice, A., Hung, A. Y., Schwarzschild, M. A., Hayes, M. T., …, & International Genetics of Parkinson Disease Progression (IGPP) Consortium (2023). Mitochondrial haplogroups and cognitive progression in Parkinson’s disease. Brain, 146(1), 42-49. https://doi.org/10.1093/brain/awac327

Vancouver

Liu G, Ni C, Zhan J, Li W, Luo J, Liao Z, et al. Mitochondrial haplogroups and cognitive progression in Parkinson’s disease. Brain. 2023;146(1):42-49. doi:10.1093/brain/awac327

BibTeX
@article{Liu2023,
  author = {Liu, Ganqiang and Ni, Chunming and Zhan, Jiamin and Li, Weimin and Luo, Junfeng and Liao, Zhixiang and Locascio, Joseph J and Xian, Wenbiao and Chen, Ling and Pei, Zhong and Corvol, Jean-Christophe and Maple-Grødem, Jodi and Campbell, Meghan C and Elbaz, Alexis and Lesage, Suzanne and Brice, Alexis and Hung, Albert Y and Schwarzschild, Michael A and Hayes, Michael T and Wills, Anne-Marie and Ravina, Bernard and Shoulson, Ira and Taba, Pille and Kõks, Sulev and Beach, Thomas G and Cormier-Dequaire, Florence and Alves, Guido and Tysnes, Ole-Bjørn and Perlmutter, Joel S and Heutink, Peter and van Hilten, Jacobus J and Barker, Roger A and Williams-Gray, Caroline H and Scherzer, Clemens R and International Genetics of Parkinson Disease Progression (IGPP) Consortium, International Genetics of Parkinson Disease Progression (IGPP) Consortium},
  title = {Mitochondrial haplogroups and cognitive progression in Parkinson’s disease},
  journal = {Brain},
  year = {2023},
  volume = {146},
  number = {1},
  pages = {42--49},
  doi = {10.1093/brain/awac327}
}
Kostenlos starten →